Announcement on Progress in Repurchasing Shares through Call Auction
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(603351)"Nanjing Well Pharmaceutical Group Co., Ltd."Announcement on Progress in Repurchasing Shares through Call Auction
Filed with SSE · Stock code 603351 ·
6ix is reading this filing.
View original source (Shanghai Stock Exchange)Nanjing Well Pharmaceutical Group Co. Ltd. on 6ix
Story so far
- (603351)"Nanjing Well Pharmaceutical Group Co., Ltd."Announcement on Initial Repurchase of Shares through Call Auction
- (603351)"Nanjing Well Pharmaceutical Group Co., Ltd."Announcement on Addition of a Dedicated Securities Account for Share Repurchase
- (603351)"Nanjing Well Pharmaceutical Group Co., Ltd."Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders of Unrestricted Shares Concerning Share Repurchase
Earlier from Nanjing Well Pharmaceutical
- (603351)"Nanjing Well Pharmaceutical Group Co., Ltd."Announcement on Initial Repurchase of Shares through Call Auction
- (603351)"Nanjing Well Pharmaceutical Group Co., Ltd."Announcement on Addition of a Dedicated Securities Account for Share Repurchase
- (603351)"Nanjing Well Pharmaceutical Group Co., Ltd."Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders of Unrestricted Shares Concerning Share Repurchase
- Announcement on Key Operating Data for the First Half of 2026
- Announcement on Share Pledge and Release of Share Pledge by Shareholder Holding More Than 5% of the Shares
Follow Nanjing Well Pharmaceutical into a list and get an email when it puts out news.
Follow Nanjing Well Pharmaceutical